What type of pelvic inflammatory disease does Chlamydia trachomatis cause that results in vaginal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chlamydia Causes Endometritis and Salpingitis Leading to Abnormal Uterine Bleeding

Chlamydia trachomatis causes pelvic inflammatory disease primarily through endometritis (inflammation of the uterine lining) and salpingitis (inflammation of the fallopian tubes), which directly results in abnormal vaginal bleeding, particularly intermenstrual bleeding (metrorrhagia) and postcoital bleeding. 1, 2

Pathophysiology of Bleeding in Chlamydial PID

The mechanism involves direct canalicular spread from the endocervix upward to the endometrium and fallopian tubes 1. This ascending infection causes:

  • Endometrial inflammation with infiltration of plasma cells, macrophages, and lymphocytes 3
  • Disruption of the endometrial lining leading to irregular shedding and bleeding
  • Cervicitis that can cause postcoital or intermenstrual spotting

Clinical Presentation

Women with chlamydial PID presenting with bleeding typically have:

  • Irregular vaginal bleeding (metrorrhagia) - reported in 26-39% of cases 2, 4
  • Postcoital bleeding
  • Abnormal vaginal discharge (39% of cases) 4
  • Pelvic pain (46% of cases) - though notably, bleeding may occur with minimal pain 4
  • Deep dyspareunia 5

Critical Pitfall to Avoid

Do not dismiss abnormal bleeding as a minor symptom - it is a significant marker of chlamydial infection. In one study, 48% of women with abnormal uterine bleeding tested positive for C. trachomatis, demonstrating that the prevalence of chlamydia in women with abnormal bleeding is substantially underestimated 3. The presence of macrophages in endometrial tissue is the strongest predictor of chlamydial infection in these cases 3.

Types of PID Inflammation

Chlamydia causes two main patterns:

  1. Acute endometritis - inflammation of the uterine lining, the primary source of bleeding 1, 3
  2. Salpingitis - fallopian tube inflammation that may be subclinical 1

Between 10-40% of untreated chlamydial cervicitis progresses to symptomatic PID, with even higher rates of subclinical endometritis detected on biopsy 1.

Diagnostic Markers

When evaluating bleeding with suspected chlamydial PID, look for:

  • Cervical motion tenderness or adnexal tenderness on exam 5
  • Mucopurulent cervicitis on speculum exam
  • Elevated inflammatory markers in endometrium (plasma cells, macrophages, lymphocytic foci) 3

Management Implications

Treat immediately with broad-spectrum antibiotics covering both C. trachomatis and N. gonorrhoeae when PID is suspected, as 10% of women have dual infections 1, 5. The bleeding typically resolves with appropriate antimicrobial therapy targeting the underlying infection 6, 7.

Screen and treat sexual partners simultaneously to prevent reinfection, which is critical since the high reinfection rate can perpetuate chronic endometritis and bleeding 4.

References

Research

Pelvic inflammatory disease.

Infectious disease clinics of North America, 1994

Research

Association between Chlamydia trachomatis and abnormal uterine bleeding.

American journal of reproductive immunology (New York, N.Y. : 1989), 2007

Research

Infectious Vaginitis, Cervicitis, and Pelvic Inflammatory Disease.

The Medical clinics of North America, 2023

Research

Management of Pelvic Inflammatory Disease in Clinical Practice.

Therapeutics and clinical risk management, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.